INVO Fertility's Participation in the Upcoming Investor Conference
INVO Fertility, Inc. (Nasdaq: IVF), a prominent healthcare fertility company, is set to make a significant impact at the Lytham Partners Fall 2025 Investor Conference. This important event is scheduled for September 30, 2025, and allows the Company to connect with investors through a webcast and one-on-one meetings.
Details on the Company Webcast
On September 30, 2025, at 5:00 p.m. ET, INVO Fertility will host a webcast presentation that can be accessed via the conference's home page. This online presentation will highlight the Company’s advancements and strategies in the fertility sector. A replay will be available for those who cannot attend the live event, ensuring that a wider audience can engage with the insights shared.
Exploring One-on-One Meetings
In addition to the webcast, INVO Fertility's management team will facilitate virtual one-on-one meetings throughout the conference. This provides investors a unique opportunity to engage directly with the Company’s leadership. Interested parties are encouraged to reach out to Lytham Partners to secure a meeting or register for the event.
About INVO Fertility
Founded to revolutionize access to assisted reproductive technology (ART), INVO Fertility is focused on building, acquiring, and operating fertility clinics, including their specialized INVO Centers. These centers are dedicated to providing the innovative intravaginal culture (IVC) procedure, enabled by the state-of-the-art INVOcell medical device. This device is groundbreaking as it allows fertilization and early embryo development to occur in vivo within the woman’s body, resulting in a more affordable and personal experience for patients compared to traditional ART options.
Impact of INVOcell Technology
The IVC procedure, facilitated by INVOcell, offers comparable results to traditional IVF treatments but at a significantly lower cost. With two operational INVO Centers and an IVF clinic in the U.S., the Company also distributes INVOcell to third-party fertility clinics, expanding access to this revolutionary technology. By providing a more connected and intimate treatment experience, INVO Fertility aims to support patients on their journey to parenthood.
Getting in Touch
For those seeking additional information about INVO Fertility or its initiatives, the Company is readily available for inquiries. Steve Shum, the CEO, leads the charge in engaging with potential investors and answering questions related to the Company's vision and strategy. You can reach him directly at 978-878-9505 or via email.
Frequently Asked Questions
What is the purpose of the Lytham Partners Fall 2025 Investor Conference?
The conference provides a platform for companies to present their strategies and engage with potential investors through webcasts and meetings.
How can I access the INVO Fertility webcast?
The webcast can be accessed by visiting the Lytham Partners conference homepage, where it will be available live and for replay.
What is the significance of INVOcell technology?
INVOcell allows fertilization and early embryo development to occur within the body, offering patients a more affordable and personal ART experience.
Who can I contact for more information about INVO Fertility?
Inquiries can be directed to Steve Shum, CEO of INVO Fertility, or through their investor contact at Lytham Partners.
What are the benefits of attending one-on-one meetings with INVO Fertility management?
These meetings provide investors a unique opportunity to gain insights from management about the Company's future plans and performance.
